Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer C Price

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Harm Reduction Journal|January 28, 2024
High prevalence of hepatitis B virus susceptibility among persons undergoing community-based hepatitis C virus treatmentCatherine Campusano, Rachel Kanner, Claire McDonell, et al.
Journal of Virus Eradication|September 25, 2023
Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBVMinhee Kang, Jennifer C Price, Marion G Peters, et al.
Maternal Health, Neonatology and Perinatology|August 15, 2025
Weight gain in infancy and metabolic dysfunction-associated steatotic liver disease (MASLD) in a prospective birth cohort of Latino childrenSarah L Maxwell, Jennifer C Price, Emily R Perito, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 22, 2021
Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virusIsabel Campos-Varela, Jennifer L Dodge, Norah A Terrault, et al.
AIDS (London, England)|August 11, 2022
Controlled attenuation parameter accurately detects liver steatosis in people with HIVMaria Duarte, Phyllis Tien, Yifei Ma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2024
The Obstacle is the Way: Finding a Path to Hepatitis C EliminationVincent Lo Re, Jennifer C Price, Steven Schmitt, et al.
Frontiers in Public Health|April 25, 2024
Screening for social determinants of health among populations at risk for MASLD: a scoping reviewRebecca G Kim, April Ballantyne, Molly B Conroy, et al.
Pediatric Obesity|March 7, 2024
Food insecurity is a risk factor for metabolic dysfunction-associated steatotic liver disease in Latinx childrenSarah L Maxwell, Jennifer C Price, Emily R Perito, et al.
Hepatology (Baltimore, Md.)|May 16, 2024
The obstacle is the way: Finding a path to hepatitis C eliminationVincent Lo Re, Jennifer C Price, Steven Schmitt, et al.
The Journal of Nutrition|September 11, 2019
Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United StatesIlya Golovaty, Phyllis C Tien, Jennifer C Price, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Harm Reduction Journal|January 28, 2024
High prevalence of hepatitis B virus susceptibility among persons undergoing community-based hepatitis C virus treatmentCatherine Campusano, Rachel Kanner, Claire McDonell, et al.
Journal of Virus Eradication|September 25, 2023
Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBVMinhee Kang, Jennifer C Price, Marion G Peters, et al.
Maternal Health, Neonatology and Perinatology|August 15, 2025
Weight gain in infancy and metabolic dysfunction-associated steatotic liver disease (MASLD) in a prospective birth cohort of Latino childrenSarah L Maxwell, Jennifer C Price, Emily R Perito, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 22, 2021
Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virusIsabel Campos-Varela, Jennifer L Dodge, Norah A Terrault, et al.
AIDS (London, England)|August 11, 2022
Controlled attenuation parameter accurately detects liver steatosis in people with HIVMaria Duarte, Phyllis Tien, Yifei Ma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2024
The Obstacle is the Way: Finding a Path to Hepatitis C EliminationVincent Lo Re, Jennifer C Price, Steven Schmitt, et al.
Frontiers in Public Health|April 25, 2024
Screening for social determinants of health among populations at risk for MASLD: a scoping reviewRebecca G Kim, April Ballantyne, Molly B Conroy, et al.
Pediatric Obesity|March 7, 2024
Food insecurity is a risk factor for metabolic dysfunction-associated steatotic liver disease in Latinx childrenSarah L Maxwell, Jennifer C Price, Emily R Perito, et al.
Hepatology (Baltimore, Md.)|May 16, 2024
The obstacle is the way: Finding a path to hepatitis C eliminationVincent Lo Re, Jennifer C Price, Steven Schmitt, et al.
The Journal of Nutrition|September 11, 2019
Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United StatesIlya Golovaty, Phyllis C Tien, Jennifer C Price, et al.
Pageof 10